$18.78-1.23 (-6.15%)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks in United States.
Adient plc in the Consumer Cyclical sector is trading at $18.78 with a market capitalization of $1.5B. Wall Street consensus targets $29.75 (12 analysts), implying a +58.4% move over the next 12 months. The stock is currently near its 52-week low of $17.68, remaining 10.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.93Bβ | $3.87Bβ | $3.64Bβ | $3.69Bβ | $3.74B |
| Gross Profit | $235.00Mβ | $257.00Mβ | $217.00Mβ | $247.00Mβ | $237.00M |
| Operating Income | $99.00Mβ | $119.00Mβ | $87.00Mβ | $123.00Mβ | $108.00M |
| Net Income | $25.00Mβ | $27.00Mβ | -$22.00Mβ | $18.00Mβ | $36.00M |
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks in United States. Its automotive seating solutions include complete seating systems, me...

Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AGCO, ADNT and AEM have been added to the Zacks Rank #5 (Strong Sell) List on August 24th, 2026.

Adient (NYSE:ADNT) executives said the automotive seating supplier expects to finish fiscal 2026 in line with commitments and enter fiscal 2027 with continued revenue growth, improving business performance and margin expansion, supported by Americas onshoring wins, China growth and automation invest

China growth and automation investments offset Middle East headwinds.
ADNT's Q3 earnings miss estimates despite a sales beat, as higher commodity and freight costs and Middle East disruptions pressure margins.